This post is sponsored by LifeScience Alley.
As life science companies look to control costs and adapt to new healthcare regulations and models, effectively managing supply chains is critical. On November 20, at the 2013 LifeScience Alley Conference in Minneapolis, Minnesota, experts from 3M Health Care, FedEx Healthcare Solutions, Medtronic, Inc. and Mayo Clinic will offer insight into how businesses can effectively and internally reduce cost and increase customer satisfaction through global supply chain management.
Speakers for this panel include:
- Randy Berger, Managing Director, FedEx Worldwide Services, Healthcare Solutions
- Aaron Jorgensen, Senior Director of Medtronic Global Supply Chain Logistics Transportation, Trade and License Compliance
- Brian Melchiori, Lean Six Sigma and Supply Chain Director for 3M Health Care
- Karen Wolfe, System Analyst SCM ERP for Mayo Clinic
Early Registration has been extended through Thursday, November 7, so be sure to register NOW at www.LifeScienceAlleyConference.org/attendees/registration.
In addition to addressing internal cost containment, Breakout Sessions at this year’s conference — “Healthcare Transformation — Surviving the Shift” — will examine several areas of external pressure facing life science organizations and identify opportunities to adapt to the evolving healthcare marketplace.
Policy/Regulatory Track
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
In Breakout Session one, speakers from St. Jude Medical, Immucor, Inc., FDA-CDRH and the Medical Device Innovation Consortium (MDIC) will discuss “Going Beyond Regulatory Approval and Getting Back to the Science”. Hear how the MDIC’s public-private partnership with FDA will transform your work — from the R&D process to regulatory approval to end-user interface.
In the second Policy/Regulatory session, experts from Medtronic, Inc., Health Advances, LLC and Covidien Vascular Therapies will explore “Comparing Cost, Time, and Complexity — Regulatory and Reimbursement Global Case Studies”, illustrating obstacles encountered and opportunities discovered.
Innovation Track
“Engineering Around the Data” will feature speakers from Medtronic, Inc., Mill City Innovation & Collaboration Center and Worrell Design. Panelists will explore how companies developing medical devices, health IT apps and therapeutic medicines can better understand Big Data in order to treat patients at the individualized level.
If you are an engineer, inventors or intra-preneurs within your company, attend “How to Pitch Your Great Idea” to hear representatives of Boston Scientific Corporation, Cenix BioScience USA, Inc. and the University of Minnesota offer their best advice to help you analyze your ideas, more clearly articulate your best ones, and develop a strong value proposition for others.
Business/Finance Track
“Alternative Funding Options in a Challenging Market — Keeping Your Eye on the Ball” will feature speakers from Bayside Materials Technology, Seryx Biomedical, Inc., Lindquist & Vennum LLP and Medtronic, Inc., focusing on new ways to attract meaningful capital for your medical device, biotech, pharmaceutical, or health IT company.
Finally, “Where in the World — Creating a Virtual Global Company” will offer mock case studies to help you find the best places to identify the new technologies, find the best talent, manufacture product, conduct efficient and effective clinical trials and access the highest potential markets. Speakers will represent Abingworth, Galil Medical, Leomics Associates, Inc., Nelsen BioMedical and Techne/R&D Systems.
